ReviewCancers2024

Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC).

Teresa Del Giudice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.